www.bna.com Expert Evidence Report
HomeIndexTable of CasesFeedbackwww.bna.com

Printable version (PDF) 

INDEX
Vol. 10, Nos 1-24, pp. 1-616
Jan. 4 - Dec. 20, 2010

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

    PATENTS
      – Biotechnology, expert reports held to high standards, 564
      – Damages
        – – Hypothetical negotiations-based calculations
          – – – Allowed (Fed. Cir.), 311
          – – – Reasonableness, Daubert analysis of expert testimony, 608
        – – Trial judge proper gatekeeper of testimony (Fed. Cir.), 9
      – Expert not barred from working for client's former litigation opponent (Tex. App.), 65
      – Extra-sweet pineapples, selective facts testimony inadmissible (2d Cir.), 557
      – Infringement, jury acted within discretion in crediting prior art expert (Fed. Cir.), 209
      – Legal malpractice, failure to conduct prior art search or patentability analysis (Fed. Cir.), 107
      – Royalty damages, failure to link licensing to infringement dooms claim (Fed. Cir.), 118
    PENNSYLVANIA
      – Air pollution, vinyl chloride discharges, average exposure determination and cancer cluster failure to show classwide exposure (E.D. Pa.), 144
      – Asbestos occupational exposure re smoking as cause of pleural thickening (Pa.), 389
      – Design defects, malfunction theory of vending machine fire, testimony based on speculation improper (E.D. Pa.), 66
      – Pharmaceuticals, Prempro-caused breast cancer, jury rejects causation testimony (Pa. C.P.), 116
      – Qualifications, psychiatric injuries, psychiatric nurse practitioner qualified (M.D. Pa.), 315
      – Work product doctrine yield to discovery of expert communications (Pa. Super. Ct.), 486
    PESTICIDES
    PHARMACEUTICALS
      – Accutane
        – – Failure to warn, expert's study not following own methodology unreliable (N.J. Super. Ct.), 81
        – – Inflammatory bowel disease, statistical proof on incidence in general public (N.J. Super. Ct.), 414
      – Antitrust, indirect purchaser class action denied certification (E.D. Pa.), 510
      – Baycol-caused muscle damage, failure to rule out alternatives (8th Cir.), 133
      – Bendectin to vaccine-caused autism, evolving judicial scrutiny, practitioner analysis, 237
      – Biotechnology, expert reports held to high standards, 564
      – Disclosure, FDA proposed expansion of application and clinical findings information, misuse potential, 451
      – Fentanyl patch, spectrometry test of blood goes to weight (Tex. App.), 202
      – Fosamax, bone jaw disorder
        – – Causation expert testimony (S.D.N.Y.), 83
        – – Inconclusive proof prompts dismissal (2d Cir.), 556
      – Gadolinium-caused Nephrogenic Systematic Fibrosis, expert admissible (N.D. Ohio), 257
      – Levaquin, ghostwriting of expert and scientific literature, evidence admissible (D. Minn.), 557
      – Metoclopramide-caused tardive dyskinesia, treating physician general causation testimony fails to establish (S.D. W.Va.), 605
      – Minocycline-caused vision loss, warning labels, expert admission concerning adequacy sufficient to deny summary judgment (M.D. Ga.), 164
      – Motrin-caused blindness, exclusion of label with expert's handwritten warning suggestions proper (Cal. App. Ct.), 533
      – Neurotin
        – – Lethargy and disorientation, expert refusal to link drug dooms suit (D. Mass.), 449
        – – Suicide, off-label use, economist testimony on marketing allowed, testimony of FDA worker involved in drug application allowed (M.D. Tenn.), 228
      – Paxil, failure to warn of suicide risk, testimony relying on class of drugs upheld (S.D. Ind.), 206
      – Phenylpropanolamine-caused neurological illness, methodology fails Daubert (Iowa), 105
      – Prempro-caused breast cancer, jury rejects testimony (Pa. C.P.), 116
      – Provera, Premarin, and Prempro, trial court failure to perform Daubert analysis, drugmakers seek review (U.S., rev sought), 279; (rev den), 343
      – Requip, linking to gambling fails (5th Cir.), 161
      – Seroquel-caused diabetes, testimony barred for failure to consider alternative causes (11th Cir.), 191
      – Trasylol labeling, regulatory expert testimony on unilateral update of label barred (S.D. Fla.), 534
      – Tylenol, cirrhosis of the liver, failure to prove causation (N.Y. Sup. Ct.), 63
      – Zyprexa litigation, confidential documents, permanent injunction bars disclosure (2d Cir.), 437
    PHYSICIANS
      – Attorney misrepresentation of finding, claims against law firm (E.D. Pa.), 560
      – CAT scan interpretation, medical expert need not have same credentials as preparer of source material (Ind. App. Ct.), 413
      – Controlled substances, over prescribing, admission of video showing proper patient exams harmless error (6th Cir.), 10
      – Disciplinary proceedings
        – – Consulting medical expert testimony not admissible (Tex. App.), 259
        – – Investigative records ordered subject to discovery (Fla. Dist. Ct. App.), 487
      – Medical malpractice
      – Qualifications
        – – Anesthesiologist, epidural steroid injections, recent and relevant experiences satisfy Va. clinical practice requirement (E.D. Va.), 312
        – – Animal feed antibiotic link to injuries beyond treating physician expertise (N.M. Ct. App.), 515
        – – Cardiac treatment, certified cardiologists qualified (Tex. App.), 166
        – – Cardiologist testimony on physician assistant standard of care (Tenn.), 358
        – – Community standards knowledge
        – – Emergency room communications standard of care, patients with limited English proficiency (Tex. App.), 384
        – – Neurologist with head trauma experience qualified testify on obstetrician/gynecologist standard of care re hematoma-caused injury (Tex. App.), 599
        – – Pharmacist not barred from testifying on standard of care (D.S.D.), 252
        – – Practice of same specialty not required (D. Md.), 582
        – – Pre-suit certificate, waiver of board certification in same specialty (N.J.), 383
        – – Testimony of hospital former chief surgeon improperly excluded (Del.), 466
        – – Thoracic certified surgeon never performing specific procedure (Tex. App.), 511
        – – Vascular surgeon qualified to address kidney damage (Tex. App.), 552
        – – Vertebroplasty, radiologist practicing substantially same specialty (Mo.), 362
      – Treating physician
        – – Animal feed antibiotic link to injuries beyond treating physician expertise (N.M. Ct. App.), 515
        – – Back injury, orthopedic surgeon barred from expressing opinion on effect of work-related vibrations on condition (E.D. Okla.), 286
        – – Causation testimony subject to same rules as retained experts (8th Cir.), 513
        – – Expert report required where causation opinion not determined at time of treatment (7th Cir.), 463
        – – Lay testimony status requires knowledge and opinions obtained through course of treatment (S.D.), 110
        – – Metoclopramide-caused tardive dyskinesia, general causation testimony fails to establish (S.D. W.Va.), 605
        – – Vocational rehabilitation expert opinion of fitness for work rejected in favor of treating physician (5th Cir.), 231
        – – Work product doctrine yield to discovery of expert communications (Pa. Super. Ct.), 486
    POLICE
      – Age discrimination, class actions, failure to establish commonality and or use well accepted methodology (N.D. Cal.), 471
      – Controlled substances, visual identification insufficient (N.C. Ct. App.), 534
      – Drunk driving field sobriety test, Frye standards applicability to opinion of officer (Kan.), 363
      – Excessive use of force claim, former officer testimony not relevant (2d Cir.), 363
      – Motor vehicle accident, opinion on speed (Mass. App. Ct.), 445
    POLLUTION
    PREEMPTION
      – Regulatory compliance defense, analysis, 268
    PRIVILEGED COMMUNICATIONS
      – Discovery, e-mails inadvertently sent to expert required to be disclosed (S.D. Ohio), 108
      – E-mail retrieval of personal messages to attorney on company laptop violated privacy right (N.J.), 193
      – Inadvertent waivers, analysis of court rulings on Fed. R. Evid. 502, 94
      – NIH peer-review data, privilege recognized (D. Del.), 281
      – Zyprexa litigation, confidential documents, permanent injunction bars disclosure (2d Cir.), 437
    PROCEDURE
      – Continuance motion, denial not equivalent to exclusion of expert (Ga.), 552
    PRODUCT SAFETY AND LIABILITY
      – Bicycle carbon-fiber fork defect, testimony of aircraft-coating expert not conducting tests speculative (2d Cir.), 227
      – Boiler repair, metallurgist qualifications, lack of practical experience not bar (5th Cir.), 532
      – Class actions
        – – Conclusive ruling on admissibility required at certification stage (7th Cir.), 201
        – – Daubert considerations at pre-certification stage, analysis, 348
      – Crane defect, feasibility of alternative design lacking (SC Ct. App.), 471
      – Design defects
      – Disclosure, FDA proposed expansion of application and clinical findings information, misuse potential, 451
      – Discovery sanctions, water heater gas control, reports from nontestifying experts in settled cases not basis (Ind. App. Ct.), 225
      – Escalator accident, res ipsa loquitur barred by causation options (5th Cir.), 280
      – Gas can explosion, evaporation rate of aged gasoline, unknown error rate and lack of literature not bar (D. Utah), 554
      – Halogen lamp fire, failure to address alternative theories (Tex.), 339
      – Hydraulic lift platform failure, expert need not address product misuse (Ill. Ct. App.), 315
      – Medical devices
      – Motor vehicles
      – Nickel, judicial notice of toxicity levels needed rejected (N.D.N.Y.), 263
      – Oil rig wire rope sling, parts maker entitled to directed verdict (Tex. App.), 367
      – Pharmaceuticals
      – Plumbing pipes, class certification, mean time to failure calculations admissibility deferred (D. Minn.), 261
      – Power tool warning sufficiency, font size, guesswork disallowed (Cal. Ct. App.), 495
      – Scientific literature use, challenging peer-reviewed material, practitioner discussion, 397
      – Timex watch straps, hexavalent chromium-caused dermatitis, untimely report rejected, conclusory report not stating relevant standards rejected (W.D. La.), 62

Contact the Webmaster at webmaster@bna.com
1801 S. Bell Street, Arlington, VA 22202 - Phone: 1-800-372-1033

Copyright © The Bureau of National Affairs, Inc. All Rights Reserved.